|
Volumn 35, Issue SUPPL. 1, 2007, Pages 26-31
|
Unravelling the mystery of malignant hyperthermia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANESTHETIC AGENT;
CAFFEINE;
CALCIUM;
CHLOROFORM;
CREATINE KINASE;
DANTROLENE;
DEXAMETHASONE;
ETHER;
HALOTHANE;
INSULIN;
LIDOCAINE;
NITROUS OXIDE;
PORPHYRIN;
PROCAINAMIDE;
PROCAINE;
SUXAMETHONIUM;
THIOPENTAL;
ABSENCE OF SIDE EFFECTS;
ANESTHESIA INDUCTION;
ANESTHESIA MECHANISM;
ARTICLE;
AUSTRALIA;
AUTOSOMAL DOMINANT INHERITANCE;
BLOOD ANALYSIS;
BLOOD PRESSURE;
CLINICAL FEATURE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
COMPOUND FRACTURE;
CREATINE KINASE BLOOD LEVEL;
CRYOTHERAPY;
CYANOSIS;
DOCTOR PATIENT RELATION;
DRUG EFFICACY;
DRUG FATALITY;
DRUG RESPONSE;
DRUG SAFETY;
FAMILY HISTORY;
GENERAL ANESTHESIA;
GENETIC ANALYSIS;
HUMAN;
HYPERVENTILATION;
LOCAL ANESTHESIA;
MALIGNANT HYPERTHERMIA;
MYOPATHY;
NEPHROLITHIASIS;
NONHUMAN;
PATIENT MONITORING;
PORPHYRIA;
PULSE PRESSURE;
REGIONAL ANESTHESIA;
SIDE EFFECT;
SPINAL ANESTHESIA;
TEMPERATURE MEASUREMENT;
UNSPECIFIED SIDE EFFECT;
URINALYSIS;
WATER IMMERSION;
|
EID: 34250612673
PISSN: 0310057X
EISSN: None
Source Type: Journal
DOI: 10.1177/0310057x0703501s05 Document Type: Article |
Times cited : (10)
|
References (13)
|